XTL Biopharmaceuticals Ltd Cash Flow Quality Index
XTL Biopharmaceuticals Ltd cash flow quality index. XTL Biopharmaceuticals Ltd (H2K2) has a Cash Flow Quality Index of -2.41x as of December 2021. Operating cash flow of €-1.05 Million is below net income of €435.00K, suggesting accrual-heavy earnings not yet converted to cash. See XTL Biopharmaceuticals Ltd (H2K2) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of XTL Biopharmaceuticals Ltd (2018–2021)
Cash flow quality index of XTL Biopharmaceuticals Ltd from 2018 to 2021. Historical Cash Flow Quality Index for XTL Biopharmaceuticals Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of XTL Biopharmaceuticals Ltd to assess how comfortably operating cash covers total debt obligations.
XTL Biopharmaceuticals Ltd Cash Flow Quality Index by Year (2018–2021)
XTL Biopharmaceuticals Ltd cash flow quality index by year from 2018 to 2021. Year-by-year earnings quality comparison for XTL Biopharmaceuticals Ltd. For the full cash flow conversion analysis, see XTL Biopharmaceuticals Ltd cash flow conversion.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -2.41x | €-1.05 Million | €435.00K | ▼ -972.8% |
| 2018 | -0.22x | €-816.00K | €3.63 Million | — |